Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

SmithKline Beecham Corporation (now GlaxoSmithKline)

SmithKline Beecham was formed in 1989 through the merger of SmithKline Beckman Corporation, a Pennsylvania corporation, and Beecham Group p.l.c., an English public limited company. SmithKline Beecham merged with Glaxo Wellcome in 2000 and is a leading global pharmaceutical company.

Search Projects

  • Vice President, Medical and Scientific Affairs-Cardiopulmonary
  • Director, Human Resources
  • Product Director, Seroxet